Business
Press Release Jan 30 2024
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 30, 2024, titled "Strides reports strong Q3FY24 Revenue and EBITDA".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 30, 2024, titled "Strides reports strong Q3FY24 Revenue and EBITDA". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd